SEARCH

SEARCH BY CITATION

References

  • Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, G., Potron, G., Colona, P., Oberling, F., Thomas, M., Tchernia, G., Jacquillat, C., Boivin, P., Lesty, C., Duault, M.T., Monconduit, M., Belabbes, S. & Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198206.
  • Cheson, B.D., Bennett, J.M., Rai, K.R., Grever, M.R., Kay, N.E., Schiffer, C.A., Oken, M.M., Keating, M.J., Boldt, D.H., Kempin, S.J. & Foon, K.A. (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-Sponsored Working Group. American Journal of Hematology, 29, 152163.
  • Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society Series B, 34, 187220.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • D'Arena, G., Musto, P., Cascavilla, N., Dell'Olio, M., Di Renzo, N. & Carotenuto, M. (2000) Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. American Journal of Hematology, 64, 275281.
  • D'Arena, G., Musto, P., Cascavilla, N., Dell'Olio, M., Di Renzo, N., Perla, G., Savino, L. & Carotenuto, M. (2001) CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia. Leukemia and Lymphoma, 42, 109114.
  • Davis, K.A., Abrams, B., Iyer, S.B., Hoffman, R.A. & Bishop, J.E. (1998) Determination of CD4 antigen density on cells: role of antibody valency, avidity, clones, and conjugation. Cytometry, 33, 197205.
  • Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M.I., Del Moro, B., Masi, M. & Amadori, S. (2001) Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood, 98, 26332639.
  • Durig, J., Naschar, M., Schmucker, U., Renzing-Kohler, K., Holter, T., Huttmann, A. & Duhrsen, U. (2002) CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia. Leukemia, 16, 3035.
  • Foon, K.A. & Gale, R.P. (1987) Staging and therapy of chronic lymphocytic leukemia. Seminars in Hematology, 24, 264274.
  • Golay, J., Lazzari, M., Facchinetti, V., Bernasconi, S., Borleri, G., Barbui, T., Rambaldi, A. & Introna, M. (2001) CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59. Blood, 98, 33833389.
  • Gratama, J.W., D'hautcourt, J.L., Mandy, F., Rothe, G., Barnett, D., Janossy, G., Papa, S., Schmitz, G. & Lenkei, R. (1998) Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry, 33, 166178.
  • Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 18481854.
  • Hamblin, T.J., Orchard, J.A., Gardiner, A., Oscier, D.G., Davis, Z. & Stevenson, F.K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood, 95, 24552457.
  • Hamblin, T.J., Orchard, J.A., Ibbotson, R.E., Davis, Z., Thomas, P.W., Stevenson, F.K. & Oscier, D.G. (2002) CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood, 99, 10231029.
  • Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B. & Gatter, K.C. (1994) A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 13611392.
  • Huh, Y.O., Keating, M.J., Saffer, H.L., Jilani, I., Lerner, S. & Albitar, M. (2001) Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia. American Journal of Clinical Pathology, 116, 437443.
  • Hultin, L.E., Matud, J.L. & Giorgi, J.V. (1998) Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator. Cytometry, 33, 123132.
  • Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. & Albitar, M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood, 98, 181186.
  • Iyer, S.B., Hultin, L.E., Zawadzki, J.A., Davis, K.A. & Giorgi, J.V. (1998) Quantitation of CD38 expression using QuantiBRITE beads. Cytometry, 33, 206212.
  • Jelinek, D.F., Tschumper, R.C., Geyer, S.M., Bone, N.D., Dewald, G.W., Hanson, C.A., Stenson, M.J., Witzig, T.E., Tefferi, A. & Kay, N.E. (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. British Journal of Haematology, 115, 854861.
  • Kaplan, F.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • McCarron, K.F., Hammel, J.P. & Hsi, E.D. (2000) Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders. American Journal of Clinical Pathology, 113, 805813.
  • Mainou-Fowler, T., Dignum, H., Taylor, P.R., Dickinson, A.M., Saunders, P.W.G., Proctor, S.J. & Summerfield, G.P. (2001) Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukemia (BCLL). Blood, 98, 322a.
  • Matrai, Z., Lin, K., Dennis, M., Sherrington, P., Zuzel, M., Pettitt, A.R. & Cawley, J.C. (2001) CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood, 97, 19021903.
  • Rai, K.R., Sawitsky, A., Cronkite, E.P., Chanana, A.D., Levy, R.N. & Pasternack, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219234.
  • Rai, K.R., Peterson, B.L., Appelbaum, F.R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G.A., Larson, R.A., Cheson, B.D. & Schiffer, C.A. (2000) Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. New England Journal of Medicine, 343, 17501757.
  • Rozman, C. & Montserrat, E. (1995) Chronic lymphocytic leukemia. New England Journal of Medicine, 333, 10521057.
  • Treon, S.P., Mitsiades, C., Mitsiades, N., Young, G., Doss, D., Schlossman, R. & Anderson, K.C. (2001) Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies. Journal of Immunotherapy, 24, 263271.
  • Zwiebel, J.A. & Cheson, B.D. (1998) Chronic lymphocytic leukemia: staging and prognostic factors. Seminars in Oncology, 25, 4259.